Search Results for: NCM-MCI-6.5 Tests 🍟 NCM-MCI-6.5 Online Test 🍰 NCM-MCI-6.5 Demotesten 📔 Suchen Sie jetzt auf ▶ www.itzert.com ◀ nach ▛ NCM-MCI-6.5 ▟ und laden Sie es kostenlos herunter 😭NCM-MCI-6.5 Zertifizierungsfragen
Antimicrobial Surveillance of Beta-Haemolytic Streptococci in Europe (EU) and North America (NA): Report from the SENTRY Program (2001)
Antimicrobial Surveillance of Beta-Haemolytic Streptococci in Europe (EU) and North America (NA): Report from the SENTRY Program (2001), Lead author: Biedenbach DJ, presented at 42nd annual Interscience Conference of Antimicrobial…
Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004)
Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America…
In Vitro Evaluation of PTK 0796 Activity Tested against Staphylococcus aureus, Including Hospital- and Community-Associated MRSA Strains from the USA and Europe
In Vitro Evaluation of PTK 0796 Activity Tested against Staphylococcus aureus, Including Hospital- and Community-Associated MRSA Strains from the USA and Europe, Lead author: Biedenbach DJ, presented at 50th annual…
Antimicrobial Activity of Ceftolozane/tazobactam Tested against Gram-negative Bacterial Isolates from Hospitalized Patients with Pneumonia in United States and European Hospitals (2012)
Antimicrobial Activity of Ceftolozane/tazobactam Tested against Gram-negative Bacterial Isolates from Hospitalized Patients with Pneumonia in United States and European Hospitals (2012), Lead author: Sader HS, presented at 53rd annual Interscience…
Chemotherapy Alliance for Neutropenics and Controlof Emerging Resistance (CANCER) Program: Initial Report from Haematology-Oncology Hospitals in North America (NA)
Chemotherapy Alliance for Neutropenics and Controlof Emerging Resistance (CANCER) Program: Initial Report from Haematology-Oncology Hospitals in North America (NA), Lead author: Jones RN, presented at 42nd annual Interscience Conference of…
Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-Negative Bacilli (NFB), Including Imipenem-Non-Susceptible (IMP-NS) Strains, and ESBL-producing Enterobacteriaceae (ENT)
Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-Negative Bacilli (NFB), Including Imipenem-Non-Susceptible (IMP-NS) Strains, and ESBL-producing Enterobacteriaceae (ENT), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of…
Activity of tigecycline tested against vancomycin-resistant enterococci, including clonal complex-17 E. faecium strains, isolated in Europe
Activity of tigecycline tested against vancomycin-resistant enterococci, including clonal complex-17 E. faecium strains, isolated in Europe, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and…
Update on Telavancin Activity Tested against a Collection of Gram-Positive Pathogens from US Hospitals (2007-2009)
Update on Telavancin Activity Tested against a Collection of Gram-Positive Pathogens from US Hospitals (2007-2009), Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy…
Ceftaroline-avibactam Tested against Contemporary (2012) Isolates Collected from United States Hospitals with Well Characterized ß-lactamases
Ceftaroline-avibactam Tested against Contemporary (2012) Isolates Collected from United States Hospitals with Well Characterized ß-lactamases, Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy…
Assessment of Pathogens and Resistance (R) Patterns Among Intensive Care Unit (ICU) Patients in North America (NA): Initial Report from the SENTRY Antimicrobial Surveillance Program (2001)
Assessment of Pathogens and Resistance (R) Patterns Among Intensive Care Unit (ICU) Patients in North America (NA): Initial Report from the SENTRY Antimicrobial Surveillance Program (2001), Lead author: Stephen J,…
